Traded Sep 24, 2026 · largest single transaction ~$6.1K
Show all 2 transactions
Sep 24, 202614K · @ $0.4386
DetailsOfficial recordSep 24, 202614K
DetailsOfficial record
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
BLTE · NASDAQ · Pharmaceutical Preparations · Foreign private issuer
Belite Bio (BLTE) · oqro.io/stocks/BLTE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$164.36−5.61 (−3.30%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Including 11 routine filings (option exercises, tax withholding, grants, gifts). Open-market trades only
Traded Sep 24, 2026 · largest single transaction ~$6.1K
Sep 24, 202614K · @ $0.4386
DetailsOfficial recordSep 24, 202614K
DetailsOfficial recordInsider filing
Traded Oct 29 · filed 2 days later
Not classified as an open-market trade.
Insider filing
Traded Oct 29 · filed 2 days later
Not classified as an open-market trade.
Hendrik Peter Scholl (Chief Medical Officer) sold ~$33K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$20K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$13K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$2K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$4K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$8.3K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$2.4K of Belite Bio
Planned saleHendrik Peter Scholl (Chief Medical Officer) sold ~$340 of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$2.12M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.73M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.7M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.57M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.45M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.19M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.19M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.16M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$1.15M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$908K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$1.18M of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$1.17M of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$851K of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$810K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$908K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$879K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$889K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$857K of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$623K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$806K of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$573K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$730K of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$535K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$717K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$689K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$659K of Belite Bio
Planned saleHao-yuan Chuang (Chief Financial Officer) sold ~$654K of Belite Bio
Planned saleYu-hsin Lin (Chief Executive Officer) sold ~$475K of Belite Bio
Planned saleNo earnings release (8-K Item 2.02) is on file for BLTE, so its insider trades cannot be placed against one.